Simultaneous administration of antogmiR-21 and IM enhanced the effectiveness of IM and induced apoptosis in CD34+ CML cells, while leaving normal CD34+ cells unaffected [156]. Here, CD34 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.